CoriLDainesMD

Pediatric Pulmonology • Tucson, AZ

Associate Professor, Pediatrics, University of Arizona College of Medicine

Join to view full profile

Dr. Daines is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Daines' full profile

Already have an account?

Office
535 N Wilmot Rd
Suite #101
Tucson, AZ 85711
Phone+1 520-694-9988

Fax+1 520-694-9917

Education & Training

University of North Carolina HospitalsFellowship, Pediatric Pulmonology, 1996 - 1999
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 1993 - 1996
Saint Louis University School of MedicineClass of 1993

Certifications & Licensure

AZ State Medical License 2006 - 2025
OH State Medical License 1999 - 2007
NC State Medical License 1996 - 1999
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

Top Doctors:Arizona State Castle Connolly, 2013

Clinical Trials

Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Start of enrollment: 2013 Jun 01
Completed
Phase 2
Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis Start of enrollment: 2009 May 01
Completed
Not Applicable
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Start of enrollment: 2014 Jun 01
Completed
Phase 3
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF Start of enrollment: 2014 Jan 01
Completed
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations Start of enrollment: 2016 Dec 01
Completed
Phase 2
Feasibility of a Mobile Medication Plan Application in CF Patient Care Start of enrollment: 2018 Sep 05
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

431 citations
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Dominic Keating, Gautham Marigowda, Lucy D. Burr, Cori L. Daines, Marcus A. Mall
The New England Journal of Medicine. 2018-10-18
26 citations
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR ...
Patrick A. Flume, Reta Fischer Biner, Damian G Downey, Cynthia A. Brown, Manu Jain
The Lancet. Respiratory Medicine. 2021-02-10
15 citations
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least oneallele: 144-week interim results from a 192-week open-...
Cori L Daines, Elizabeth Tullis, Stefano Costa, Rachel W Linnemann, Marcus A Mall
The European Respiratory Journal. 2023-12-01

Journal Articles

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
Cori Daines, Bonnie W Ramsey, The New England Journal of Medicine
Outcome Measures for Pediatric Laryngotracheal Reconstruction: International Consensus Statement
Reza Rahbar, Michael J Rutter, Catherine K Hart, Christopher T Wootten, Jonathan B Ida, R Paul Boesch, David R White, Shelagh A Cofer, Karen Zur, Cori Daines, Peter B ..., The Laryngoscope

Press Mentions

France’s Vaccination-Pass ExperimentAugust 12th, 2021

Grant Support

Aztreonam For Inhalation In Patients With Cystic FibrosNational Center For Research Resources2004